Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quipt Home Medical (QIPT) Capital Expenditures (2020 - 2025)

Historic Capital Expenditures for Quipt Home Medical (QIPT) over the last 6 years, with Q4 2025 value amounting to -$2.1 million.

  • Quipt Home Medical's Capital Expenditures rose 4365.66% to -$2.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $14.0 million, marking a year-over-year increase of 17585.46%. This contributed to the annual value of $12.4 million for FY2025, which is 1979.06% up from last year.
  • Latest data reveals that Quipt Home Medical reported Capital Expenditures of -$2.1 million as of Q4 2025, which was up 4365.66% from $1.8 million recorded in Q3 2025.
  • In the past 5 years, Quipt Home Medical's Capital Expenditures ranged from a high of $11.8 million in Q3 2023 and a low of -$3.7 million during Q4 2024
  • For the 5-year period, Quipt Home Medical's Capital Expenditures averaged around $972900.0, with its median value being -$50000.0 (2021).
  • Its Capital Expenditures has fluctuated over the past 5 years, first plummeted by 326250.0% in 2021, then surged by 2281346.15% in 2023.
  • Quipt Home Medical's Capital Expenditures (Quarter) stood at -$973000.0 in 2021, then plummeted by 33.71% to -$1.3 million in 2022, then soared by 220.75% to $1.6 million in 2023, then plummeted by 334.31% to -$3.7 million in 2024, then soared by 43.66% to -$2.1 million in 2025.
  • Its Capital Expenditures stands at -$2.1 million for Q4 2025, versus $1.8 million for Q3 2025 and $5.2 million for Q2 2025.